Loading company…
Irish medical technology company whose NEUROMARK System uses radiofrequency energy to treat chronic rhinitis.
Neurent Medical Ltd., based in Galway, Ireland, develops treatments for chronic rhinitis, centered on the NEUROMARK System, which uses proprietary radiofrequency technology to create lesions that interrupt posterior nasal nerves. The company sells the system directly to healthcare institutions and practitioners on a B2B basis. In February 2026 it raised EUR 62.5 million in Series C funding led by MVM Partners, with Sofinnova Partners, EQT Life Sciences, Atlantic Bridge, Fountain Healthcare Partners and Enterprise Ireland participating. Brian Shields co-founded the company and is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in